Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like CoTec to Host Investor Update January 14, 2026 Valeura Ranked No. 1 of Canada’s Top Growing... October 3, 2025 Domestic Metals Begins Trading on OTCQB July 22, 2025 Platinum Price Surges to 11 Year High, Breaks... June 28, 2025 Finlay Minerals Announces Grant of Stock Options December 11, 2025 Top 5 Canadian Mining Stocks This Week: Bayhorse... December 6, 2025 Apex Resources: Strategic Critical Minerals Assets in North... October 30, 2025 S&P Global: Mining Sector Sees Mixed Q1, Next... May 17, 2025 World Bank: Oil Glut to Drive Commodities Prices... October 31, 2025 Gold Price Hits New Record, Breaks US$4,500; Silver,... December 24, 2025